All News #Library
Rare Diseases
Shilpa Biologicals And Mabtree Biologics Secure ODD From USFDA
14 Mar 2026 //
INDPHARMAPOST
FDA Approves Shilpa & mAbTree Therapy for Rare Blood Disorder
30 Jan 2026 //
INDPHARMAPOST

Market Place
Sourcing Support